Clinical Trials Logo

Cerebral Venous Sinus Thrombosis clinical trials

View clinical trials related to Cerebral Venous Sinus Thrombosis.

Filter by:
  • None
  • Page 1

NCT ID: NCT05448248 Completed - Clinical trials for Cerebral Venous Sinus Thrombosis

Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)

Start date: August 20, 2022
Phase:
Study type: Observational

This study will investigate the epidemiology, risk factors, diagnostics, treatment, and the long-term prognosis of cerebral venous thrombosis in China.

NCT ID: NCT05291585 Recruiting - Clinical trials for Cerebral Venous Sinus Thrombosis

The Dedicated Venous Sinus Thrombectomy Stent for Endovascular Treatment of Cerebral Venous Sinus Thrombosis.

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

A prospective, single-center, open-label,randomized, controlled,non-inferiority clinical trial will be conducted to evaluate the safety and efficacy of a dedicated venous sinus thrombectomy stent for endovascular treatment of cerebral venous sinus thrombosis.

NCT ID: NCT05021198 Recruiting - Clinical trials for Cerebral Venous Sinus Thrombosis

The Norwegian Cerebral Venous Thrombosis Study

NoCVT
Start date: January 1, 2014
Phase:
Study type: Observational

The NoCVT study will investigate CVT (2014-2023) in a large Norwegian population (> 3 millions) using several approaches combining existing health registries, clinical databases and new prospectively collected clinical data to explore epidemiology, risk factors, diagnostics, treatment, and the long-term prognosis of CVT.

NCT ID: NCT04966182 Recruiting - Clinical trials for Magnetic Resonance Imaging

Application CT and MRI in Cerebral Venous Sinus Thrombosis

Start date: January 1, 2015
Phase:
Study type: Observational

Cerebral venous thrombosis (CVT) is a rare disease, and with poor prognosis. Computed tomography (CT) andmagnetic resonance imaging (MRI) are the most commonly used image modalities for patients with non-specific neurologic symptoms. We are going to assess the accuracy of CT and MRI in the differential diagnosis of CVT and cerebral venous sinus thrombosis (CVST).

NCT ID: NCT04580238 Withdrawn - Hemorrhagic Stroke Clinical Trials

Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache

Start date: December 2023
Phase: Phase 1
Study type: Interventional

Post stroke headache occurs in approximately 10-23% of all stroke patients. Its onset is shortly after experiencing a stroke, or stroke like event, and persists for at least three months. These headaches have features which resemble migraine or occur in people who have a previous history of migraine that was once infrequent. Botox is a treatment that is currently approved for the treatment of chronic migraine, that is migraine headaches occurring for at least 15 days a month for at least 3 months. Given the clinical similarity in character and frequency of post stroke headache and migraine, and the fact that stroke affects structures like the blood vessels in the brain that are also affected in migraine, this study is to investigate the possible role that Botox would have in the treatment of Post-Stroke Headache.

NCT ID: NCT04269954 Not yet recruiting - Clinical trials for Cerebral Venous Sinus Thrombosis

The Efficacy and Safety of Batroxobin Combined With Anticoagulation in Cerebral Venous Sinus Thrombosis

Start date: March 1, 2020
Phase: Phase 4
Study type: Interventional

Our previous clinical case observations showed that batroxobin combined with anticoagulation therapy can improve the sinus recanalization rate in patients with CVST, shorten the hospital stay, and increase the neurological score of patients. Its main mechanism is to inhibit thrombosis after reducing fibrinogen, and to dissolve thrombus. To further explore the safety of batroxobin combined with anticoagulation therapy for CVST, an open-label, randomized controlled (1: 1), single-center, prospective study was used. Further study on the safety and effectiveness of batroxobin combined with anticoagulation for CVST.

NCT ID: NCT03919305 Not yet recruiting - Clinical trials for Cerebral Venous Sinus Thrombosis

Cerebral Venous Thrombosis Cohort Study in China Mainland

CCC
Start date: June 1, 2019
Phase:
Study type: Observational

This study was aimed to reveal the clinical features,natural history of the diseases and current therapeutic situations of cerebral venous thrombosis (CVT) in China mainland. Blood samples and cerebrospinal fluid samples will be collected after recruitment to reveal the pathological mechanisms of CVT and identify the biomarkers for CVT.

NCT ID: NCT03273179 Recruiting - Clinical trials for Cerebral Venous Sinus Thrombosis

Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment Scales

Start date: June 1, 2017
Phase: N/A
Study type: Observational

This is a single-center, retrospective, open-label study. This study is planned to investigate the accuracy of mRS and NIHSS, comparing with the accuracy of CSF pressure and papilledema grade in assessing cerebral venous sinus thrombosis.